10x Genomics Operating Margin 2018-2025 | TXG
Current and historical operating margin for 10x Genomics (TXG) over the last 10 years. The current operating profit margin for 10x Genomics as of March 31, 2025 is -14.56%.
| 10x Genomics Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $0.63B | $-0.17B | -27.52% |
| 2024-12-31 | $0.61B | $-0.19B | -31.75% |
| 2024-09-30 | $0.63B | $-0.20B | -31.59% |
| 2024-06-30 | $0.63B | $-0.25B | -40.03% |
| 2024-03-31 | $0.63B | $-0.27B | -43.77% |
| 2023-12-31 | $0.62B | $-0.27B | -42.81% |
| 2023-09-30 | $0.59B | $-0.23B | -39.42% |
| 2023-06-30 | $0.57B | $-0.18B | -31.34% |
| 2023-03-31 | $0.54B | $-0.18B | -33.21% |
| 2022-12-31 | $0.52B | $-0.17B | -32.56% |
| 2022-09-30 | $0.50B | $-0.16B | -31.94% |
| 2022-06-30 | $0.50B | $-0.14B | -27.51% |
| 2022-03-31 | $0.50B | $-0.08B | -16.83% |
| 2021-12-31 | $0.49B | $-0.05B | -10.59% |
| 2021-09-30 | $0.46B | $-0.45B | -97.17% |
| 2021-06-30 | $0.41B | $-0.50B | -121.92% |
| 2021-03-31 | $0.33B | $-0.52B | -157.36% |
| 2020-12-31 | $0.30B | $-0.53B | -178.60% |
| 2020-09-30 | $0.26B | $-0.13B | -50.38% |
| 2020-06-30 | $0.25B | $-0.08B | -30.28% |
| 2020-03-31 | $0.26B | $-0.05B | -17.80% |
| 2019-12-31 | $0.25B | $-0.03B | -12.20% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.513B | $0.611B |
| 10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.103B | 58.65 |
| Doximity (DOCS) | United States | $12.505B | 55.48 |
| Hims & Hers Health (HIMS) | United States | $11.626B | 96.19 |
| Tempus AI (TEM) | United States | $10.538B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $5.092B | 0.00 |
| Hinge Health (HNGE) | United States | $4.422B | 0.00 |
| Privia Health (PRVA) | United States | $2.509B | 187.09 |
| Inspire Medical Systems (INSP) | United States | $2.340B | 34.41 |
| Enovis (ENOV) | United States | $1.625B | 8.59 |
| Phreesia (PHR) | United States | $1.607B | 0.00 |
| Omnicell (OMCL) | United States | $1.416B | 27.28 |
| Schrodinger (SDGR) | United States | $1.410B | 0.00 |
| Azenta (AZTA) | United States | $1.331B | 58.06 |
| Clover Health Investments (CLOV) | United States | $1.109B | 0.00 |
| Evolent Health (EVH) | United States | $1.057B | 0.00 |
| Claritev (CTEV) | United States | $0.934B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.623B | 0.00 |
| Veradigm (MDRX) | United States | $0.514B | 0.00 |
| Standard BioTools (LAB) | United States | $0.496B | 0.00 |
| Talkspace (TALK) | United States | $0.418B | 125.00 |
| Zepp Health (ZEPP) | Netherlands | $0.360B | 0.00 |
| Carlsmed (CARL) | $0.337B | 0.00 | |
| Butterfly Network (BFLY) | United States | $0.335B | 0.00 |
| TruBridge (TBRG) | United States | $0.284B | 49.76 |
| Nyxoah SA (NYXH) | Belgium | $0.253B | 0.00 |
| Outset Medical (OM) | United States | $0.227B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.215B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.197B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.183B | 0.00 |
| CapsoVision (CV) | United States | $0.182B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.126B | 0.00 |
| American Well (AMWL) | United States | $0.114B | 0.00 |
| CareCloud (CCLD) | United States | $0.113B | 5.14 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.092B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.074B | 0.00 |
| Pulmonx (LUNG) | United States | $0.063B | 0.00 |
| 111 (YI) | China | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.033B | 0.00 |
| Zhongchao (ZCMD) | China | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.020B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |